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l.  In  the  context  of  a  pcoph:·s  Europ•:.  the  Cnmmission  :1tt:lchcs  t:rc:lt  imp<~iUncc  tu 
~implifying and clarifying Community l:1w  sn  :1s  to. make it  clearer and nwrc accc-.sihlc  to 
the ordinary citizen, thw; giving him new  upportunitics and the chance to nnkc usc  of the 
specific  rights it gives him. 
This  aim  cannot be  achieved  so  lnng  as  numerous  provisions  that  have  been  amended 
several  times,  often  quite  subst:mti:dly.  t"l'main  sc1ttered,  so  that  they  must  he  sought 
partly in  the original instrument and partly in  bter amending nncs.  Considerable research 
work, comparing many different instrumcnts,  is  thus needed to identify the currcnt rules. 
For  this  reason  a  consolidation  of  rules  th:1t  h:\\"e  frequently  been  amendcd  is  also 
essential if Community law  is  to he  clear :md  tr:1nsparent. 
2.  On 1 April  1987 the Commission therefme decided tu  in:;truct its staff that all  legislative 
measures should be consolidated after llilJllilfJ:. th:m  ten  amendments, stressing that this 
was  a  minimum  requirement  and  that  tkpartmcnts  ,;hnuld  cndc:wour  tu  consolidate  at 
.even  shorter  intervals  the  texts  for  which  thc:y  W<:IT  responsible.  to  ensure  that  the 
Community rules were clear and readily umkr,:tandabk. 
3.  The Conclusions of the Presidency of the  Edinburgh European Council (Decemher 1992) 
confirmed this, stressing the importance uf  l~lil..;J.ili'e consolidation as it offers cert:linty as 
to  the law applicable to a  given  matter at  a given  time. 
It  must  be  undertaken  in  full  compliance  with  the  normal  Community  legislative 
procedure. 
Given th<lt  no changes of substance may be made tu the instruments affected hy lq;i>lative 
eonsolidatiqn,  Parliament,  the  Council  and  the  Commission  have  :1greed,  by  an 
interinstitutional agreement dated 20  December 199-l,  that an accelerated procedure may 
he used for the fast-track adoption of codification in:;trument>. 
4.  The  purpose  of  this  proposal  ( 1)  for  lcgisbtive  Cllnsolidation  of  Council  Directive 
90/679/EEC of 26 November 1990 on the protection of workers from the risks related to 
exposure to biological agents at work (sevt:nth  individual  Directive within the meaning of 
Article  lfi  (1)  of Directive 89/391/EEC), is  to undertake official codification of this type. 
The new Directive will  supersede the various  Directives incorporated in  it e): their con-
tent is  fully  preserved, and they are brought together  ~ith...Q.D.)y__such formal  amendments 
as  are required by the codification exercise  itself. 
5.  This  legislative  consolidation  proposal  was  drawn  up  on  the  basis  of  a  preliminary 
consolidation, in  all  the official  languages, of Directive 90/679(EEC  and the instruments 
amending  it,  carried  out  by  the  Office  fur  Offtcial  Publications  of  the  European 
Communities, by means of the  data-processing~stem referred to in the conclusions of the 
European  Council  meeting  at  Edinburgh.  Although  the  articles  h:l\"e  been  given  new 
numbers, the old numbering  has  been retained  in  the  margin for  ease of reference; the 
correlation between the old and new numbers  is  shown in  a  table set out in  Annex IX to 
the consolidated Directive. 
e)  Entered in the legislative programme fc1r  J9CIS. 
e)  See Annex VIII, Part A of this Proposal. ( 1) 
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PROPOSAL FOR A 
EUROPEAN  PARLIAMENT AND  COl1NClL DIRECTlVE 
911  ()/9 EEC- !\'' 
9.  fl.  1'!9'1 
nn  the protection of workers from  risks related to exposure to biological agents at work 
r seventh  individual Dil'ecti\·e nithin the meaning of Article  16  (1) of Directive 89/391/EEC) 
fl  !E EUROPEAN P:\RLIAJ\.IENT t'u'\10 THE COUNCIL OF. 
TilE EUROPEAN UNION, 
f-LJ\·ing  regard to  the Treaty  establishing the  European 
Community, and in particular Article  137  (2) thereof, 
f-JJ\·ing  regard to  the proposal from  the  Commission, 
I Ll\'ing regard to the opinion of the Economic and Social 
Committee e). 
I l:l\'ing  regard  to the  opinion of the  Committee of tl1e 
Re~ions  (~ ), 
A<.:ting  in  accordance  with  the  procedure  laid  down  in 
:-\rtide 251  of the Treaty e), 
Whereas  Council  Directive  90/679/EEC  . of 
::'.n  :--.Jovemher  1990  on  the:  protection  of workers  from 
risks  related  to  exposure  to  biological  agents  at  work 
( Sc:venth  individual  Directive  within  the  meaning  of 
..-\rtide  16  ( 1)  of  Directive  89/391/EEC) ('1)  has  been 
'ubstantially  amended on  a  number  of  occasions (5): 
\\ hereas for the sake of clarity and rationality Directive 
90 6 79/E EC should therefore be  codified: 
\Vhercas  compliance  with  the  minimum  requirements 
Jesigned  to  guarantee  a  better st<muard  of safety  and 
helth as regards the protection of workers from the risks 
related to exposure to biological agents at work is  essen-
tial  to ensure the safety and health of workers; 
11)  OJ C  ... 
{2)  OJC.  .. 
{3)  OJ C. .. 
(~)  OJ L  37~. 31. 12.1990, p.  1.  Directive  as  last amended by 
Commission  Directive  97!65/EC  (OJ  L  335,  6.  12.  1997, 
p. 17). 
(5)  See Annex VIII, Part A. 
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5.  90/679/EEC (3) 
( 4) 
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(6) 
(7) 
(8) 
(9) 
(10) 
Whcrc~1s this  Dircdive is  an  individual  Dirc~:tivc within 
the  meaning  of  Article  I  11  (I)  of  Coun~:il  Directive 
89/.:i91/EEC  of  12  June  1989  on  t~te  ihtroduction  of 
measures to .encourage  improvements  in  the safety and 
health of workers at work ( 1  ); whereas the provisions of 
that  Dire~:tive are therefore fully  applicable to the expo-
sure of workers to biological agents, without prejudice to 
more  stringent  and/or  specific  provisions  contained  in 
this  Dire~:tive; 
Whereas more precise knowledge of the risks involved in 
exposure  to  biological  agents can be obtained  through 
the keeping of records; 
Whereas  the  list  and  classification  of  the  biological 
agents must be examined  regularly  and  revised  on, the 
basis of new scientific data; 
Whereas, for a number of biological agents details addi-
tional to their  classifi~:ation should be given; 
Whereas employers must keep  abreast of new develop-
ments in  technology with  a view  to improving  the pro-
tection of workers' health and safety; 
\Vhereas  preventive  measures should  be  taken for  the 
protection of the health and  safety of workers ex-posed 
to  biological agents; 
Whereas this Directive constitutes a practical aspect of the 
realization of the social dimension of the internal market; 
Whereas, pursuant to Council Decision  74/325/EEC (2), 
the Advisory Committee on Safety,  Hygie'n.e  and Health 
Protection  at  Work  should  be  consulted  by  the 
Commission with a view to the formulation of proposals 
in  this field:  whereas it was  so  consulted over the for-
mulation of proposals for  the  Council directives embo-
died in  this Directive: 
( 11)  Whereas  this  Directive  is  without  prejudice  to  the 
obligations of the Member States concerning the dead-
lines for transposition as  set out in Annex VIII, Part B, 
HAVE ADOPTED THIS DIRECTIVE; 
(1)  OJ L 183, 29.  6.  1989, p.  1. 
(2)  OJ L 185, 9.  7.  1974, p.  15:  Decision as last amended by 
the Act of Accession of Austria, Finland and Sweden. 
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GE:"<ERAL  PROYISIO.\/S 
Article  I 
Objective 
I.  This  Directive  has  as  its  aim  the  prutection  of 
workers  against  risks  to  their health  and  safety,  including 
the  prevention of such risks,  arising or likely tel  ~~rise  from 
exposure  to biological  Z~gents at work. 
It lays  dnwn particular minimum provisiuns in  this area. 
'1  Directive  89/39l!EEC  shall  apply  tully  to  the  \\hole 
area rd.:rred to in paragraph 1, withnut prejudice to more 
string.:nt  and/or  specific  provisions  contained  in  this 
Directi\'e. 
3.  This  Directive  sh~!ll  apply  without  fX•:judice  tu  the 
provisinns  nf  Council  Directi\'c  90/21 WEEC e)  and  of 
Cuuncil  Directive 9Ui22il;EEC (2). 
A11ic/e  2 
flefinitions 
For the purpose of this Directive: 
(a)  ·biological agents shall mean micro-organisms, includ-
ing  those  which  ha\·e  been  genetically modified.  cell 
cultures and human  endopar~tsites, which may be able 
to  pro\·oke any infection, allergy or toxicity; 
(b)  ·micro-organism'  shall mean a  microbiological  entity. 
cellular or  non-cellular,  capable  of replication  or of 
transferring genetic material: 
(c)  ·cell  culture·  shall  mean  the  in-vitro  growth  of cells 
derived from multicellular organisms. 
·Biolngical agents' shall he classified into four risk groups, 
according to their level of risk of infection: 
I.  group I  biological agent means one that is unlikely to 
cause  hum~m disease: 
( 1)  Cl>Uncil  Directi':e  91}1219/EEC  of  23  April  1990  on  the 
wntained use of genetically modified micro-organisms (OJ 
L  117,  8.  5.  1990,  p.  1  ).  Directi\·c  as  last  amended  by 
Directive 98/SJ!EC (OJ  L  330, 5.  12.  1998, p.  13). 
(:)  Council  Directive  90.'220/EEC  of  2.'  April  1990  on  the 
deliberate  release  into  the  environment  of  genetically 
modified  organisms  (OJ  L  117,  8  5.  1990,  p.  15). 
Directive  as  last  amended  bv  DiJective  9/;3'i;EC  (OJ 
L 169,  27.  6.  1997, p. i2).  -
(adapted) 
90/n79/EEC - IV 
9. 6.  1999 
A11iclc 1 
A1ticle 2 2.  group  2  binlngil.:al  agent  means  one  that  can  cn1sc 
human disease and might he a hazard to workers; it is 
unlikely to spread to  the community; there is  usually 
effective prophylaxis or treatment available: 
3.  group  3  biological  agent  means one  that  can  cause 
severe human disease and present a serious hazard to 
workers;  it  may  present  a  risk  of spreading  to  the 
community, hut  there  is  usually  effective. prophylaxis 
or treatment available: 
4.  group 4 biological agent means one that causes severe 
human disease and is  a serious hazard to workers:  it 
may present a high risk of spreading to the communi-
ty;  there  is  usually  no effective prophylaxis  or treat-
ment available. 
A11icle 3 
Scope - Determination and assessment of risks 
I.  This  Directive  shall  apply  to  activities  in  which 
workers are or are potentially expqsed to biological agents 
as  a  result of their work. 
2.  In  the case of .any  activity  likely  to involve  a  risk of 
exposure to biologkal agents,  the nature, degree and dur-
ation of workers' exposure must be determined in order to 
make  it  possible  to assess  any  risk  to  the workers'  health 
or safety and to lay down  the measures to be taken. 
In  the  case  of  activities  involving  exposure  to  several 
groups of biological  agents,  the  risk  shall  be assessed on 
the basis of the danger presented by all hazardous biologi-
cal agents present. 
The  assessment  must  be  renewed  'regularly  and  in  any 
event when ;my change occurs in the conditions which may 
affe1..'t  workers' exposure to biological agents. 
The  employer  must  supply  the  competent authorities,  at 
their  request,  with  the  infonnation  used  for  making  the 
assessment. 
3.  The  assessment  referred  to  in  paragraph 2  shall  be 
conducted  on  the  basis  of  all  available  information 
including: 
(a)  classification of biological agents which are or may be 
a hazard to human health, as referred to in Article 18; 
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A111dc 3 (h)  n:commendations fn>m  a  cumpetent ;1uthority which 
indicate that the  hiolo~ical  a~ent should he controlled 
in  order to protect wurkers"  health when workers arc 
or  may  he  exposed  to  such  a  biological  agent  as  a 
result of their work: 
(c)  information on diseases 11hich  may he contractetl as a 
result of the wmk of the workers; 
(d)  potential  ;lller~enic or  toxi~t:nic effects  as  a  restllt of 
the work of the workers: 
(e)  knowledge of a  dise;~>c from which a  worker is  found 
to be suffering and which has a direct connection with 
his work. 
Article 4 
Application of the 1arious Articles in  relation to 
assessment of risks 
I.  If the results of tht! assessment referred to in Article 3 
show  that  the  exposure  and/or potential  exposure  is  to  a 
group  I biological agent, with no identifiable health risk to 
workers, Articles 5  to  17  and Article  19  shall  not apply. 
I !mvever, point  I  of Annex VI  should he  ohst!r~·cd. 
2.  If the n:sults of the assessment referretl to in Article 3 
show that the activity  dncs  not involve  a  deliberate  inten-
tion to work with or usc  a  biological  agent but may result 
in  the wnrkers"  bcing expnsed  to  a  biological  agent,  as in 
the  course  of the  ;lctivities  for  which  an  intlicative  list  i> 
given  in  Annex  I,  Articles  5,  7,  8,  10,  11,  12,  13  and  14 
shall apply unless the results of the assessment referred to 
in  Article 3  show them to he unnecessary. 
CHAPTER II 
E:\IPLOYERS'  OBLIGATIO~S 
A11iclc  5 
Replacement 
The employer shall  a\·oid  the use  of a  harmful biological 
agent if the nature of the activity so permits, by replacing 
it  with  a  biological  agent  which,  under  its  conditions  of 
use,  is  not  dangerous  or  is  less  dangerous  to  workers' 
health,  as  the  case  may  be,  in  the  present  state  of 
knowledge. 
A11icle  6 
Reduction of risks 
I.  Where  the  results  of the  assessment  referred  to  in 
Article  3  reveal  a  risk  to  workers·  health  or  safety, 
workers' exposure must be prevented. 
7 
90/n7WEEC 
91),(,79/EEC  - I\" 
9. 11.  I9<J<J 
A11iclc 4 
A1ticlc 5 
Article fi 2.  Where  this  is  not  tec.:hnically  practicable.  having 
regard to the activity and the risk assessmt.:nt referred to in 
Artide 3,  the risk of exposure must he reduced to as low a 
level as  necessary in  order to protect adequately the health 
and safety of the workers concerned,  in  particubr by the 
following measures which are to be <lpplied  in  the light of 
the results of the assessment referred to  in  Article 3: 
(a)  keeping  as  low  as  possible  the  number  of workers 
exposed or likely to be exposed; 
(b)  design  of  work  processes  and  engineering  control 
measures  so as  to  avoid or minimize  the  release  of 
biological agents into the place of work; 
(c)  collective protection measures  ~nd/or, where exposure 
cannot be avoided by other means, individual protec-
tion measures; 
(d)  hygiene measures compatible with the aim of the pre-
vention  or  reduction  of  the  accidental  transfer  or 
release of a biological agent from the workplace; 
(e)  use of the  biohazard  sign  depicted  in  Annex II  and 
other relevant warning signs; 
(f)  drawing up plans to deal with accidents involving bio-
logical agents; 
(g)  testing,  where it  is  necessary and technically possible, 
for the presence, outside the primary physical confine-
ment, of biological agents used at work; 
(h)  means  for  safe  collection,  storage  and  disposal  of 
waste  by  workers  including  the  use  of secure  and 
identifiable containers, after suitable treatment where 
appropriate; 
(i)  arrangements for  the  safe handling and transport of 
biological agents within the workplace. 
Article  7 
Information for the competent authority 
1.  Where  the  results  of the  assessment  referred  to  in 
Article 3 reveal risk to workers' health or safety, employers 
shall,  when  requested,  make  available  to  the  competent 
authority appropriate information on: 
(a)  the results of the assessment; 
(b)  the activities in which workers have been exposed or 
may have been exposed to biological agents: 
(c)  the number of workers exposed; 
(d)  the  name  and capabilities  of the  person responsible 
for safety and health at work; 
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A11icle  7 (c)  the  protective and preventive measures taken,  includ-
ing working procedures· and methods; 
(f)  an emergency plan for the protection of workers from 
exposure  to group  3  or a  group  4  biological  agent 
which  might  result  from  a  .loss  of  physical 
containment. 
2.  Employers shall inform forthwith the competent auth-
ority of any  accident or incident which  may  have  resulted 
in  the release. of a biological agent and which could cause 
severe human infection and/or illness. 
3.  The  list  referred  to  in  Article  11  and  the  medical 
record referred to in Article 14 shall be made available to 
the  competent  authority in  cases  where  the  undertaking 
ceases  activity,  in  accordance  with  national  Jaws  and/or 
practice. 
A11icle 8 
Hygiene and individual protection 
I.  Employers shall be obliged, in the case of all activities 
for which  there is  a risk to  the health or safety of workers 
due  to  work  with biological  agents,  to  take  appropriate 
measures to ensure that: 
(a)  workers do not eat or drink  in  working areas where 
there is a  risk of contamination by biological  agents; 
(b)  workers  are  provided  with  appropriate  protective 
clothing or other appropriate special clothing; 
(c)  workers are provided with  appropriate and  adequate 
washing  and  toilet  facilities,  which  may  include  eye 
washes  and/or skin antiseptics; 
(d)  any necessacy protective equipment is: 
properly stored in a well-defined place; 
checked  and  cleaned  if possible  before,  and  in 
any case after, each use; 
is repaired, where defective, or is replaced before 
further use; 
(e)  procedures are specified for taking, handling and pro-
cessing samples of human or animal origin. 
2.  Working  clothes and protective equipment, including 
protective clothing referred  to in  paragraph 1,  which  may 
be contaminated by biological agents, must be removed on 
leaving the working area and, before taking the measures 
referred  to  in  the  second  subparagraph,  kept separately 
from  other clothing. 
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A1tjck 8 The employer must ensure that such dothin,g  and pmtcc-
tivc cqyipmcnt is dewntaminated and deaned or, if neces-
sary,  destroyed. 
3.  Workers  may  not  be  charged  for  the  cost  of  the 
measures referred to in  paragraphs l  and 2. 
Article 9 
Information and training of workers 
I.  Appropriate measures shall be taken by the employer 
to ensure that workers and/or any workers' representatives 
in the undertaking or establishment receive sufficient  and 
appropriate training, on the basis of all  available informa-
tion, in particular in  the form of information and instruc-
tions, ·concerning: 
(a)  potential risks to health; 
(b)  precautions to be taken to  prevent exposure; 
(c)  hygiene  requirements:' 
(d)  wearing and use of protective equipment and clothing: 
(e)  steps to be taken by workers in  the case  of incidents 
and to prevent incidents. 
2.  The training shall  be: 
(a)  given at the beginning of work involving contact with 
biological agents 
(b)  adapted to take account of new or changed risks; and 
(c)  repeated periodically if necessary. 
Article 10 
Worker inforntation in particular cases 
l.  Employers  shall  provide  written  instructions  at  the 
workplace and, if appropriate, display notices which shall, 
as a minimum, include the procedure to be followed in the 
case of: 
(a)  a  serious accident or incident  inv~lving the handling 
of a biological agent; 
(b)  handling a group 4 biological  agent. 
2.  Workers shall immediately report any accident or inci-
dent involving  the  handling  of a  biological  agent  to  the 
person in charge or to the person responsible  for  safety 
and health at work. 
3.  Employers shall  inform forthwith the workers and/or 
any workers'  representatives  of any  accident  or incident 
which  may  have  resulted  in  the  release  of a  biological 
agent and which could cause severe· human infection and/ 
or illness. 
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Article lO In  aduition, employers shall inform the workers and/or any 
workers'  representatives  in  the  unuertaking  or  establish-
ment  as  quickly  as  possible  when  a  serious  accident  or 
incident lH:curs,  of the causes thereof, and of the measures 
taken or to be  taken to  rectify the situation. 
4.  Each worker shall  have  access  to  the  information on 
the  list  referred  to  in  Artide  II  which  {elates  to  him 
personally. 
5.  Workers  and/or  any  workers'  representatives  in  the 
undertaking or establishment shall  have  access  to anony-
mous collective information. 
o.  Employers shall  provide  workers  and/or  their  repre-
sentatives,  at their request, with  the  information provided 
for in  Article 7 (I). 
Article 11 
List of exposed workers 
1.  Employers  shall  keep  a  list  of workers  exposed  to 
group  3  and/or  group  4  biological  agents,  indicating  the 
type  of work  done  and,  whenever possible,  the biological 
agent to which they have  been exposed, as well  as  records 
of exposures, accidents and  incidents,  as  appropriate. 
2.  The I  ist  referred. to  in  paragraph  I  shall  be kept for 
at least  10  years following  the  end of exposure, in accord-
ance with  national laws and/or practice. 
In  the  case  of  those  exposures  which  may  result  in 
infections: 
(a)  with biological  agents known  to be  capable of estab-
lishing  persistent or latent infections: 
(b)  that, in the light of present knowledge, are undiagnos-
able until illness develops many years later; 
(c)  that  have particularly long incubat.ion  periods before 
illness develops; 
(d)  that result in  illnesses which  recrudesce at times over 
a long period despite -treatment, or 
(c)  that may have serious long-term sequelae, 
the  list  shall  be kept for  an  appropriately longer time  up 
to  40 years following  the last known exposure. 
3.  The doctor referred to in Artide 14 and/or the com-
petent  authority for  health  and  safety  at  work,  and  any 
other person  responsible  for  health  and  safety  at  work, 
shall  have  access to the list  referred to in  paragraph 1. 
II 
90/o79,EEC 
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A11iclc 11 /lrticlc  12 
Consultation and participation of workers 
Con~uJtation  and  p;1rticipation  of  workers  amlior  their 
representatives in  connection \vith  matters covered by this 
Directive shall  take  place in  accordance with  Article  II  of 
Directive  SlJ/.391/EEC. 
Article 13 
Notification to  the competent authority 
I.  Prior  notification  shall  be  made  to  the  competent 
authority of the use  for  the first  time of: 
(a)  group 2 biological agents: 
(b)  group 3 biological agents: 
(c)  group 4 biological  agents. 
The notification shall be made at least 30  days before the 
commencement of the work. 
Subject. to  paragraph  2,  prior  notification  shall  also  he 
made  of  the  use  for  the  first  time  of  each  subsequent 
group  4  biological  agent  and  of  any  subsequent  new 
group 3  biol,lgi~.:al  agent  where  the  employer  himself 
provisionally classifies that biological agent. 
2.  Laboratories providing a diagnostic service in  relation 
to group 4 biological agents shall be required only tci  make 
an initial notification of their intention. 
3.  Renotification  must  take  place  in  any  .case  v.·here 
there are  substantial  changes  of importance  to  safety  or 
health at work to  processes and/or procedures which ren-
der the notification out of date. 
4.  The notification referred to in paragraphs  1,  2 and 3 
shall include: 
(a)  the  name .  and  address  of  the  undertaking  and/or 
establishment: 
(b)  the  name and capabilities  of the person  responsible 
for safety and health at work; 
(c)  the results of the assessment referred to in Article 3; 
(d)  the species of the biological agent; 
(e)  the  protection  and  preventive  measures  that  are 
envisaged. 
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.·lnic/c 13 CH.-\PTER Ill 
:\IISCELLA.'IEOUS PROVISIO:"'S 
Article  14 
Health surveillance 
J.  The J\.fembcr States shall establish, in accordance with 
national  laws  and  practice,  arrangements for carrying out 
relevant  health  surveillance  of  workers  for  whom  the 
results of the assessment referred to· in Article 3  reveal  a 
risk  to  health or safety. 
2.  The arrangements referred to in paragraph 1 shall be 
such  that  each  worker  shall  be  able  to  undergo,  if 
;1ppropriate,  relevant health surveillance: 
(a)  prior to  exposure; 
(b)  at  regular intervals thereafter. 
Those  arrangements  sh:.~ll  be  such that it is  directly poss-
ible  to  implement  individual  and  occupational  hygiene 
measures. 
3.  The assessment referred to in Artide 3 should ident-
ify  those  workers  for  whom  special  protective  measures 
may be  required. 
\Vhen  necessary, effective vaccines should he  made avail-
able for those workers who are not already immune to the 
biological  agent to which  they are exposed or are likely to 
be  exposed. 
\Vhen employers make vaccines available., they should take 
account  of the  recommended code of practice set out in· 
Annex VII. 
If a worker is  found to be suffering from an infection and/ 
or illness which is  suspected to be the result of exposure, 
the doctor or authority responsible for health surveillance 
of workers  shall  offer such  surveillance  to  other workers 
who  have  been similarly exposed. 
In that event, a  reassessment of the risk of exposure shall 
be carried out in accordance with Article 3. 
4.  In  cases where  health surveillance  is  carried out,  an 
individual medical record shall be kept for at least 10 years 
following  the end of exposure, in accordance with national 
laws  and practice. 
In  the  special  cases  referred  to  in Article  11  (2)  second 
subparagraph.  an  individual  medical record shall  be  kept 
for an  appropriately longer time up to 40 years following 
the last known exposure. 
5.  The doctor or authority responsible for health surveil-
lance shall  propose any protective or preventive measures 
to be taken in  respect of any individual worker. 
6.  Infom1ation  and  ad\'ice  must  be  given  to  workers 
regarding any health SUI'\'eillance which they may undergo 
following  the end of exposure. 
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t!ltick 14 7.  ln acconlance with  n•1tional  laws  and/or practice: 
(a)  \vorkers shall have  access to the rest1lts of the health 
surveillance which concern them, and 
(b)  the workers concerned or the employer may request a 
review of the results of the  health surveillance. 
8.  Practical recommendations for the health surveillance 
of workers are given  in  Annex IV. 
9.  All cases of diseases or death identified in accordance 
with  national  laws  and/or  practice  as  resulting  from 
occupational exposure to biological agents shall be notified 
to the competent authority. 
Article  15 
Health and ,·eterinary care facilities other than diagnostic 
laboratories 
l.  For  the  purpose  of  the  assessment  referred  to  in 
Article 3,  particular attention should be paid to: 
(a)  uncertainties about the presen<>e  of biological agents 
in human patients or animals  and  the  materials and 
specimens taken .from them; 
(b)  the hazard represented by biological agents known or 
suspected to be  present in  human patients or animals 
and materials and specimens taken from them; 
(c)  the risks posed by the nature of the work. 
2.  Appropriate measures  shall  be  taken  in  health  and 
veterinary care facilities in order to protect the health and 
safety of the workers concerned. 
The measures to be taken shall  include in particular: 
(a)  specifying appropriate decontamination  and disinfec-
tion procedures, and 
(b)  implementing procedures enabling contaminated waste 
to be handled and disposed of without risk. 
3.  In isolation facilities where there are human patients 
or  animals  who  are,  or  who  are  suspected  of  being, 
infected with group 3 or group 4 biological agents, contain-
ment measures shall  be selected from  those  in Annex V 
column A, in order to minimize the risk of infection. 
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A1ticlc 15 Article  /6 
Special measures for industrial processes, lahnratnries 
and animal rooms 
I.  The following measures must he taken in  lahor~Jtt)ries, 
including diagnostic laboratories, and in  roon~> for bbnra-
tory  animals  which  have  been  deliberately  infected  with 
group 2,  3  or 4 hiulogicat agents or which  are or are  sus-
pected to  he  carriers of such agents: 
(a) 
(h) 
Laboratories  carrying  out  work  which  invoh·e~  the 
handling  of  group  2,  3  or  4  biological  agents  for 
research,  development,  teaching  or  diagnostic  pur-
poses  shall  determine  the  containment  measures  in 
accordance  with  Annex  V,  in  order to  minimize  the 
risk of infection. 
Following  the  assessment  referred  to  in  Article  3, 
measures  shall  he  determined  in  accordance  \Vith 
Annex  V,  after fixing  the  physical  containment  level 
required  for  the  biological  agents  according  to  the 
degree of risk. 
Activities  involving the handling of a  biological agent 
''- must he carried out: 
only  in  working  areas corresponding to  at  least 
containment  level  2,  for  a  group  2  biological 
agent: 
only  in  working  areas corresponding to  at  least 
containment  level  3,  for  a  group  3  biological 
agent; 
only  in working  areas corresponding  to  at  least 
containment  level  4,  for  a  grou;:>  4  biological 
agent. 
(c)  Laboratories  handling  materials  in  respect  of which 
there exist uncertainties about the presence of biologi-
cal  agents which may cause human disease but which 
do  not  have  as  their  aim  working  with  biological 
agents as such (i.e.  cultivating or concentrating them) 
should  adopt  containment level  2  at least.  Contain-
ment levels  3 or 4  must be  used,  when appropriate, 
where  it  is  known  or  it  is  suspected  that  they  are 
necessary,  except  where  guidelines  provided  by  the 
competent  national  authorities  show  that,  in  certain 
cases, a  lower containment level  is  appropriate. 
2.  The  following  measures  concerning  industrial  pro-
cesses  using  group  2,  3  ot 4  biological  agents  must  be 
taken: 
(a)  The containment principles set out in the second sub-
paragraph  of  paragraph  1  (b)  should  also  apply  to 
industrial  processes  on  the  basis  of  the  practical 
measures  and  appropriate  procedures  gin:n  m 
Annex VI. 
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.-lrticlr ]f) (h)  In  m:cordance  with  the  <tSScssmcnt  of the  risk  linked 
to  the  usc  of group  2,  3 or 4 biological  ~\gents, the 
cnmpetent  authorities  may  decide  on  ~lppropriate 
measures which  must be applied to  the industrhll usc 
of such biological agents. 
3.  For all activities covered by paragraphs I and 2 where 
it has  not been possible  to  carry out a  concl\ISive  assess-
ment of a biological agent but concerning which it  ~lppears 
that the  use  envisaged might involve  a serious health risk 
for  workers,  activities  may  only  be carried  out in  work-
places where the containment level corresponds at least to 
level3. 
Article  17 
Use of data 
The Commission shall have access to the use made by the 
competent national authorities of the information referred 
to  in  Article  14 (9). 
Article  18 
Classification of biological agents 
90/679/EEC 
I.  Community classification shall be on the basis of the  (adapted) 
definitions in  the second paragraph of Article  2,  points 2 · 
to 4 (groups 2 to 4  ). 
2.  Pending  Community  claSsification  Member  States 
shall classify biological agents that are or m~y  be a hazard 
to  human  health  on  the  basis  of  the  definition  in  the 
second  paragraph  of Article 2,  points  2  to  4  (groups  2 
~~  -
3.  If  the biological agent to be assessed cannot be classi-
fied  clearly  in  one  of the ·groups  defined  in  the  second 
paragraph of Article 2,  it must be classified in the highest 
risk group among the alternatives. 
90/679JEEC - IV 
9. fl.  !91Jl) 
Atticlc 17 
d11ic/e 18 
Article  19  Attjclc 19 
Annexes 
Purely technical adjustments to the Annexes in the light of 
technical progress, changes in international regulations or 
specifications  and new  findings  in  the  field  of biological 
agents shall be adopted in accordance with the procedure 
laid down in Article  17 of Directive 89/391/EEC. 
Article 20 
Notifying the Commission 
Member States shall communicate to the  Commission the 
provisions  of national law  already adopted or which they 
adopt in the future in  the field governed by this Directive. 
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(adapted)  dtticle 20 Article 21 
Repeal 
Directive 90/679/EEC, amended by the Directives referred 
to in  Annex VIII, Part A is  repealed, without prejudice to 
the  obligations  of the  Member  States  in  respect  of the 
deadlines  for  transposition  laid  down  in  Annex VIII, 
Part B. 
References to the repealed Directive shall be construed as 
references  to  this  Directive  and  shall  be  correlated  in 
accordance with the correlation table set out in Annex IX. 
Article 22 
Entry into force 
This  Directive  enters into  force  on the twentieth day fol-
lowing  that of its  publication in  the Official Joumal of  the 
European Communities. 
Article 23 
Adressees 
This Directive  is  addressed to  the Member States. 
Done at Brussels, 
For the European Parliament  For the Cou.ncil 
The President  The President 
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I:'IIDICATI\'E LIST OF ACTIVITIES 
(Article 4 (2)) 
l.  Work  in  food  produ~:tion plants. 
2.  Work in  agriculture. 
3.  Work  activities where  there  is  contact with  animals  and/or 
products of animal llrigin. 
4.  Work  i~ health care,  including  isolation  and  pl,St  mpi·tem 
~~  . 
S.  Work  in  clinical,  veterinary  and  diagnostic  laboratories, 
excluding diat.rnostic microbiologieal  laboratories. 
6.  Work in refuse disposal plants. 
7.  Work  in  sewage purification installations. 
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RIOIIAZARD  SIG:'ol 
(Article 6 (2)  (e)) 
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COM:\IUNITY CLASSIFICATION 
(Article 18 and Article 2,  second paragraph) 
lntrudu~.:tory notes 
1.  In  line with  the  scope  of the  Dire~.:tive,  only  agents which 
are knllWD  to infect humans are to be included in  the classi-
fied list. 
Where  appropriate,  indicators  are  given  of the  toxi~.:  and 
allergic potential of these  agents. 
Animal and plant pathogens which are known not to affect 
man are excluded. 
In  drawing  up  this  list  of  classified  biologic-dl  agents 
consideration  has  not  been  given  to  genetically  modified 
micro-organisms. 
2.  The list of classified agents  is  based on the effect of those 
agents on healthy workers. 
No specific  account  is·  taken of particular effects on those 
whoie susceptibility. may be affected for one or other reason 
such  as  pre-existing  diSease,  medication,  compromised 
immunity, pregnancy or breast feeding. 
Additionai  risk  to  such  workers  should  be  considered  as 
part of the risk assessment required by  the Directive. 
In certain industrial  processes,  certain  laboratory work  or 
certain work with animals involving actual or potential expo-
sure to biological agents of groups 3 or 4,  any technical pre-
cautions taken must comply with Article 16 of the Directive. 
..  . 
3.  Biological  agents  which  have  not been classified  for  inclu-
sion in groups 2 to 4 of the list  are not implicitly classified 
in group 1. 
For  agents where  more  than one species  is  known  to  be 
pathogenic to man,  the list will include those species which 
are  known  to be  the  most  frequently  responsible  for  dis-
eases, .  together with  a  more general  reference  to the fact 
that other species of the same genus may affect health. 
When a whole  genus is  mentioned in the classified  list of 
biological  agents,  it  is  implicit  that the  species  and strains 
known to be non-pathogenic are excluded. 
4.  Where  a  strain  is  auenuated or has  lost  known  virulence 
genes, then the containment required by the classification of 
its  parent  strain  need  not  necessarily  apply,  subject  .to 
assessment appropriate for risk in the workplace. This is the 
case,  for  example,  when such  a  strain is  to be  used as  a 
product or part of a product for prophylactic or therapeutic 
purposes. 
5.  The nomenclature of classified agents used to establish this 
list reflects and is in conformity with the _latest international 
agreements of the taxonomy and nomenclature of agents at 
the time the list was prepared.  ~ 
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(adapted) 0.  The ·list  or qlassified  biological  agents  reflects. the  state of 
knowledge ar the time  that it was devised. 
It  will  be  updated  <LS  soon as it  no longer reflects the latest 
state of knowledge.  ·  · 
7.  Member Stales  arc  to  ensure  that  all  viruses  which  have 
already  been isolated  in  humans  and which  have  not been 
assessed  and  allocated  in  this  Annex  are  classifiel.l  in 
group 2  a.~  a  minimum,  except where  Member States  have 
proof that they are unlikely to cause disease in humans. 
8.  Certain  biological  agents  classified  in  group  3  which  are 
indicated  in  the  appended  list  by  twO  asterjsks  (**l  may 
present a  limited risk  of infection for workers because they 
are not normally infectious by the air-borne route. 
Member States shall  assess the containment measures to be 
applied to such agents, taking a<..'Count  of the nature of spe-
cific  activities in question and of the quantity of the agent 
involved, with  a view  to  determining whether, in particular 
circumstances,  some  of these  measures  may  be  dispensed 
with. 
9.  The  requirements  as  to containment consequent upon  the 
classificatio~  of pardsites  apply  only  to  stages  in  the  life 
t-ycle  of the parasite in which it is liable to be infectious to 
humans at the workplace. 
10.  This  list  also gives  a separate indication in cases where the 
biological  agents  are  likely  to  cause  allergic or toxic  reac-
tions,  where ari effective vaccine  is  available,  or where it is 
advisable  to keep  a  list  of exposed workers for  more than 
10 years. 
These indications are shown by the following letters: 
A:  Possible allergic effects 
D:  List of workers exposed  to this biological  agent to be 
kept  for  more  than  10  years  after  the  end  of last 
known exposqre 
T:  Toxin production 
V:  Effective vaccine available 
The  application  of  preventive  vaccination  should  take 
account of the Code of Practice given in Annex VII. 
21 
90/679/EEC- IV 
9. 6.  1999 
93/88/EEC- Art.  I (2) 
Corrigendum OJ L 217,23. 8. 1994, p. 18. BA<.'TERIA 
and slmiiar organisms 
NB:  For  biological  agents  ap~a~ing on  this  list,  "spp."  refers  to  other species 
which are known pathogens in humans. 
Biological agent 
Actinobacillus a(:tinomycetemcomitans 
Actinomadura madurae 
Actinomadum peUetieri 
Actinomyces gerencseriae 
Actinomyces israelii 
Actinomyces pyogenes 
Actinomyces spp. 
Arcanobacteriwn 
haemolyticum) 
l1aemolyticum 
BaciUus alltllmcis 
Bacteroides fragilis 
Bartonella bacillifonnis 
Bartonella  (Rochalimea)  spp. 
(Corynebacterium 
Bartonella quintana (Rochalimaea quinlana) 
/Jordetella  bronchiseptica 
Bordetella pampertussis 
Bordetel/a pertussis 
Borrelia burgdorferi 
Borrelia duttonii 
Borrelia recun-entis 
Bon-elia  spp. 
Bntcella abortus 
Bntcella canis 
Bntcella melitensis 
Bntcella su is 
Burkholderia maUei  (Pseudomonas mallei) 
Burkholderia pseudomal/ei (Pseudomonas pseudomallei) 
Campylobacter fetus 
Campylobacter jejuni 
Campylobacter spp. 
Cardiobacterium hominis 
Chlamydia pneumoniae 
Chlamydia  trachomatis 
Chlamydia psittaci (avian strains) 
Chlamydia psittaci (other strains) 
Clostridium botulinum 
Clostridium pe!fringens 
Clostridium tetani 
Clostridium spp. 
Corynebacterium diphtheriae 
Corynebacterium minutissimum 
Corynebacterium pseudotuberculosis 
Corynebacterium spp. 
Cmiella bumetii 
Edwardsiella tare/a 
Ehrlichia sennetsu (Rickettsia sennetsu) 
Ehrlichia spp. 
Eikenella corrodens 
Enterobacter aerogenes/cloacae 
Oassifica tion 
2 
2 
2 
2 
2 
2 
2 
2 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
3 
2 
2 
2 
2 
2 
2 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
2 
2 
2 
2 
2 
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97/59/EC  ~ Art.l 
93/88/EEC.,-.Art. 1 (2) Biological agent  Classification 
£ntaohactt'r spp.  2 
£11/erococcus spp.  2 
Ery·sipelotlrri.r: rlrusiopat/Jiae  _  2 
Escherichia  coli  (with  the  exception  of non-path!>geRic 
strains)  2 
Escherichia  coli,  verocytotoxigenic  strains  (e.g.  0157:H7 
or 0103) 
Flm•obacterimn meningosepticum 
Fluoribacter bozemanae (Legionella) 
Francisella  tularensis  ('IYPe  A) 
Francisella  tularensis  ('IYPe  B) 
Fusobacterium necrophonun 
Gardnerella vagina/is 
Haemophilus ducreyi 
Haemophiltu injluenzae 
Haemopl!iltts spp. 
Helicobacter pylori 
Klebsiella  atytoca 
Klebsiella pneumoniae 
Klebsiella  spp. 
Legionella pneumophila 
Legionella spp. 
Leptospira illlel'rOgans {all serovars) 
Listeria monocytogenes 
Listeria  imnot•ii 
Morganella motganii 
Mycobacterium africanum 
Mycobacterium aviwn/inlracellulare 
Mycobacterium  bovis (except BCG strain) 
Mycobacterium  chelonae 
Mycobacterium fortuitum 
Mycobacterium /cansasii 
Mycobacterium  leprae 
Mycobacterium  malmoense 
Mycobacterium marinum 
Mycobacterium  microti 
Mycobacterium paratuberculosis 
Mycobacterium scrofulaceum 
Mycobacterium  simiae 
Mycobacterium szulgai 
Mycobacterium tuberculosis 
Mycobacterium  ulcerans 
Mycobacterium xenopi 
Mycoplasma caviae 
Mycoplasma lzominis 
Mycoplasma pneumoniae 
Neisseria gononhoeae 
Neisseria meningitidis 
Nocardia  asteroides-
Nocardia  brasiliensis 
Nocardia farcinica 
Nocardia nova 
Nocardia otitidiscaviantm 
Pasteurella multocida 
Pasteurella  spp. 
Peptostreptococcus anaerobius 
3 (**) 
2 
2 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
2 
3 
2 
2 
2 
3 
2 
2 
3~ 
2 
2 
2 
2 
3 
3~ 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
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97/59/EC - Art. 1 
93/88/EEC- Art. 1 (2) Biulv&ical agent 
Pl•.·siomtmCis .tllig•·Uoides 
PmpllymiiiOIICI.f spp. 
Pn:tvJtcl/o spp. 
Proteus  111 ire~bilis 
Prott•us pmm:ti 
Proteus  t·ulge~~is 
Prot·idcllria akalifaciclls 
Pl-ot •idetrci(l rellgcri 
Prot•idencia  spp. 
Pseudomonas aentginosa 
Rlrodoeoecus equi 
Rickettsia  akari 
Rickettsia canada 
Rickettsia conorii 
Rickettsia  mo111a11a 
Rickettsia ryplri  (Rickettsia mooseri) 
Rickettsia prowazekii 
Rickettsia rickettsii 
Rickettsia tsut.tugamuslri 
Rickettsi" spp. 
Sabnonr:lla  arizonae 
Sabnu~rel/o enteritidis  . 
Sabno11ell" typllimurium 
Sabno~rl'lla paratyplzi A,  B,  C 
Sabnonclla typlri 
Sabno~rclla (other serovars) 
Serpulilra  spp. 
SlrigeUa  boydii · 
SlrigeUa  dysenteriae (l}'pe 1) 
Slrigella  dysellleriae,  other than "JYpe  1 
SlrigcUa flexneri 
SlrigeUa sonnei 
Staplryloeoccus aurtus 
Streptobacillus monilifonnis 
Strtptococcus pnelltnOIIiae 
Streptococcus pyogenes 
Streptococcus spp. 
Stn:ptococcus Sllis 
Trtponema carateum 
Treponema pallidum 
Treponema pet1enue 
Treponema  spp. 
Vrbrio  cltolerae (including El Tor) 
Vrbrio paralraemolyticus 
Vrbrio  spp. 
Ycninia  e~rterocolitica 
l~ninia pestis 
Ycninia pseudotuberculosis 
l~ninia spp. 
C!l  See paragraph 8 of the introductol}' notes. 
Cla,;.•ifi~atiun 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3!!:.) 
3!!:.) 
3 
3!!:.) 
3 
3 
3 
3 
2 
2 
2  . 2 
2 
3!!:.) 
2 
2 
2 
3!!:.) 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
.  3 
2 
2 
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Corrigendum OJ L 217, 23. 8. 1994, p.  18. 
Corrigendum OJ L 217,  23. 8. 1994, p.  18. 
Cllrrigendum OJ L 217, 23.  8.  1994, p.  18. 
Corrigendum OJ  L 217. 23. 8. 1994, p.  18. 
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97/59/EC -Art. 1 
93/88/EEC - Art. 1 ( 2) 
95/31}/EC  - Art. 1 
93/88/EEC '- Art. 1 (2) 
Corrigendum OJ  L 217, 23.  8.  1994, p.  18. Adt:llrJI'ilidac 
An'IICII'iridae 
\1RUS (*) 
I~Cl\.1-Lassa-Virus Cumplex (Old World arena viruses): 
Lassa virus 
LymphlX'}'tic  choriomeningitis  virus  (neurotropic 
strains) 
Lymphocytic choriomeningitis virus (other strains) 
Mopeia virus 
Other LCM-Lassa complex viruses 
11lcarihe-Virus-Comple.'< (New World arena viruses): 
Guanarito virus 
Junin virus 
Sabia virus 
Machupo virus 
Flexal virus 
Other T.'!caribe complex viruses 
Astro1•iridae 
Bu11ym·iridae 
Bclgmde (also ·known as Dohrava) 
Bhanja 
Bunyamwera virus 
Germiston 
Oroptluche virus 
Sin Nombre (furmerly Muerto Canyon) 
California eru."C:phalitis virus 
Hantaviruses: 
Hantaan (Korean haemorrhagic fever) 
Seoul virus 
Puumala virus 
Prospect Hill virus 
Other hantaviruses 
Nairoviruses: 
Crimean-Congo haemorrhagic fever 
Hazara virus 
Phleboviruses: 
Rift Valley fever 
Sandtly fever 
Toscana virus 
Other bunyaviridae known to be •  pathogenic 
C  aliciviridae 
Hepatitis E virus 
Norwalk virus 
Other Caliciviridae 
Coronaviridae 
Filo1•iridae 
Ebola virus 
Marburg virus 
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93/88/EEC- Art.  I(~) 
Oassific:otiun  f"otc:~ 
2 
97/59/EC - Art.  I 
~ 
3 
2 
2 
2 
4 
4 
4 
4 
3 
2 
2  93/88/EEC -Art. 1 12) 
3  97/59/EC - Art.  I 
2 
2  93/~/EEC- Art.  1 (2) 
2  97/59/EC - Art.  1 
'  3  93/88/EEC ..;,.  Art. 1 (2) 
3  97/59/EC - Art.  1 
2  93/88/EEC - Art. 1 (2) 
3 
3 
2 
2 
2 
4 
2 
3  v 
2 
2 
2 
3 (**)  97/59/EC  ..;.  Art.  1 
2  93/88/EEC - Art. 1 (2) 
2 
2 
4 
4 
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F/cn·i,·irid<lt' 
. Australia encephalitis (Murray Valley encephalitis) 
Central European tick-borne encephalitis virus 
Ahsettawv 
Hanzalova 
Hypr 
Kumlinge 
Dengue virus type  1-4 
Hepatitis C virus 
Hepatitis G virus 
Japanese B encephalitis 
Kyasanur Forest 
Luuping ill 
Omsk (a) 
Pow ass an 
Rodo 
Russian spring-summer em:ephalitis (TBE) (a) 
St Louis encephalitis 
Wesselsbron virus 
West Nile fever virus 
Yellow fever 
Other flaviviruses known to be pathugenic 
Htpaclnm•irillae 
Hepatitis B virus 
Hepatitis 0  virus (Della) (b) 
HerpcSt·iridae 
Cywmegaluvirus 
Epstein-Barr virus 
Herpesvirus simiae (B virus) 
Herpes simplex virus types 1 and 2 
Herpesvirus varicella-zoster 
Human B-lymphotropic virus (HBLV-HHV6) 
Human  herpes 1in1s  7 
Human  lte1pes virns 8 
Ortltom.I"XOI'ilidae 
Influenza viruses types A, B and C 
Tick-borne  orthom  •  ..:toviridae:  Dhori  and  Thogoto 
viruses 
Papol'al"iridae 
BK and JC viruses 
Human papillomaviruses 
Param_1:to1•iridae 
Measles virus 
Mumps virus 
Newcastle disease virus 
Parainfluenza viruses types 1 to 4 
Respiratory syncytial virus 
Pan•o1 iri dae 
Human parvovirus (B  19) 
Picomal'iridae 
Acute haemorrhagic conjunctivitis virus (AHC) 
Coxsackie viruses 
Echo viruses 
3 
3 ( "") 
3 
3 
3 
3 
3 
3(*") 
3 ("") 
3 
3 
3 ("") 
3 
3 
3 
3 
3 
3 {"") 
3 
3 
2 
3 ("") 
3 ("") 
2 
2 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
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V.D 
v.o 
D 
V (c) 
D(d) 
D (d) 
v 
v 
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93/88/EEC- Art. I (2) 
97/59/EC - Art. I  (adapted) 
93/88/EEC - Art. 1 (2) Uiulngi~al agcnl 
Hepatitis A virus (human entcrl>virus  type  72) 
Puliuvinlscs 
Rhinuviruscs 
l'o.n·irid(ll' 
Buffalopl>X virus (  e} 
Cu'-1.-pox virus 
Elephantpdx virus (f) 
Milkers' nude virus 
Molluscum  contagioium virus 
Ml>nke)")X1X virus 
Orf virus 
Rnbbitpox virus  (g) 
VaL-cinia virus 
Variola  (m<~or and  minor) virus 
Whitcpox virus ("Variola  virus") 
Yatapox virus (Tana &  Yaba) 
Rt'OI •itid  (//? 
Cultivirus 
Human rotaviruses 
Orhiviruses 
Reoviruscs 
Rett"OI•iridae 
Human immunodeficienL-y viruses 
!Iuman  T-cell  lymphotropic  viruses  (HTLV)  types  1 
and 2 
SIV (h) 
Rlrabdo1•itidac 
R<1hics virus 
Visicular stomatitis virus 
Togm•iridac 
Alfaviruses: 
Eastern equine encephalomyelitis 
Bebaru virus 
Chikungunya virus 
Everglades virus 
Mayaro virus 
Mucnmbo virus 
Ndumu virus 
O'nyong-nyong virus 
Ross River virus 
Semliki Forest virus 
Sindbis virus 
Tonate virus 
Venezuelan equine encephalomyelitis 
Western equine encephalomyelitis 
Other known alphaviruses 
Rubivirus (rubella) 
Toro1•iridae 
t.: nclassified viruses 
Equine morbillivirus 
Hepatitis vjruses  not yet identified 
2 
2 
2 
2 
2 
2 
2 
2 
3 
2 
2 
2 
4 
4 
2 
2 
2 
2 
2 
3 (**) 
3 (**) 
2 
3 
2 
3 (**) 
3 ("*) 
3 
3 (*") 
3 
2 
2 
2 
2 
3 (**) 
3 
3 
2 
2 
2 
4 
3 ("*} 
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93/88/EEC- Art. I (2) 
95/30/EC - Art 1 
95/30/EC - Art 1 
95/30/EC  - Art 1 
93/88/EEC - Art 1 (2) 
97/59/EC - Art. 1 
93/88/EEC - Art. 1 (2) 
97/59/EC - Art. 1 Biological agent 
Unconventional  aeents  associated  with  the  transmissible 
sponeiform encephalopathies (TSEs) 
Creutzfeldt-Jakob disease 
Variant Creutzfeldt-Jakob disease 
Bovine  spongiform  encephalopathy  (BSE)  and  other 
related animal TSEs (i) 
Gerstmll!ln-Striiussler-Scheinker syndrome 
Kuru 
(*)  See paragraph 7 of the introductory notes. 
(**)See paragraph 8 of the introductory notes. 
(a)  Tick-borne encephalitis. 
Classification 
3 (**) 
3 (**) 
3 (**) 
3 (**) 
3 (**) 
Notes 
D 
D (d) 
D (d) 
D (d) 
D(d) 
(b)  Hepatitis D virus is pathogenic in workers only  in  the presence of simultaneous or second-
ary infection caused by hepatitis B virus. 
Vaccination against hepatitis B virus will  therefore protect workers who are not affected by 
hepatitis B virus against 'hepatitis D virus (Delta). 
(c)  Only for types A and B. 
(d)  Recommended for work involving direct contact with these agents. 
(e)  Two  viruses  are  identified: one a buffalopox type  and the  other a variant of the Vaccinia 
virus. 
(f)  Variant of cowpox virus. 
(g)  Variant of Vaccinia. 
90/679/EEC - IV 
9.6.1999 
93/88/EEC - Art. 1 (2) 
97/65/EC - Art. 1 
97/65/EC - Art. 1 
93/88/EEC - Art.  1 (2) 
(h)  At the present there is  no evidence of disease in humans caused by  retroviruses of simian  I  95/30/EC - Art. 1 
origin. As a precaution containment level 3 is  recommended for work with them. 
(i)  There is  no  evidence  in  humans of infections caused by  the  agents responsible  for  other 
animal TSEs. Nevertheless, the containment measures for agents categorised in  risk group 
3 (**)  are recommendelf as  a precaution for laboratory work,  except for  laboratory work 
relating to an identified agent of scrapie where containment level 2 is sufficient. 
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97/65/EC - Art. 1 PARASITES 
Biulugk:ol  agent 
/kamlwmocba casrcllani 
Am.ylostoma duodcnale 
Angiosrrongylus cantont•nsis 
Anginsrrongylus  cn.rrarict~n.ris 
Ascari.r lumbricoidcs 
Ascmis suum 
Babt·sia dil•ergens 
Babesia microri 
Balamidium coli 
Bntgia malayi 
Bmgia pahangi 
Capillaria plzilippincnsis 
Capillaria spp. 
Clonorchis sinensis 
Clonorchis •·il·enini 
Ct)ptospoddium patVum 
Ct}ptospotidium spp  .. 
Cyclospora cctyercmmsis 
Dipctalont·ma streprocerca 
Diphyllobothrium /arum 
Dmcunculus mcdinensii 
Echinococcus granulosus 
Echinococcus multilocularis 
Echinococcus vogeli 
Emamoeba histolytica 
Fasciola gigantica 
Fasciola hepatica 
Fasciolopsis buski 
Giardia lamb/ill (Giardia illlestinali.r) 
Hymenolepis diminuta 
Hymenokpis nana 
Leishmania brasilimsis 
Lt'ishmania donovani 
Leishmania ethiopica 
Leishmania mexicana 
Leishmania peruviana 
Leishmania tropica 
Leishmania major 
Leishmania spp. 
Loa loa 
Mansonella ozzardi 
Mansonella perstatiS 
Naegklia fowkri 
Necator americamts 
Onchocerca vol1·ulus 
Opisthorchis felineus 
Opisthorchis spp. 
Paragonimus westennani 
Plasmodium falcipantm 
Plasmodium spp. (human and simian) 
Sarcocystis suihominis 
Schistosoma lzaematobiwn 
Sdtistosoma intercalatwn 
Schistosoma japonicum 
Cl;ossific:oti<•n 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 !.:.:1 
3.c..:..:J 
3  .c..:..:J 
2 
2 
2 
2 
2 
2 
2 
3.c..:..:J 
3.c..:..:J 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
2 
2 
2 
2 
2 
3 c.:..l 
2 
2 
2 
2 
2 
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9.o. 199<J 
93/88/EEC- Art.  I (2) 
95/30/EC - Art.  1 
93/88/EEC - Art.  I (2) 
95/30/EC - Art.  I 
95/30/EC - Art 1 
95/30/EC - Art 1 
95/30/EC - Art 1 
95/30/EC - Art.  1 
95/30/EC  - Art. 1 Hiolugical  a};I.!Ot 
Schistosoma  mansoni 
Scl!i.~to.mma nu·kungi 
Stmngyloidc.~ st,.,-comlis 
Stnmgyloidcs spp. 
Tat•nia  saginata 
Taenia  soliwn 
Tuxocam  canis 
Toxoplasma gomlii 
1iichindla spimlis 
7iiclwris trichiura 
7i)panusuma brucei bmcei 
7i)pcmosoma bntcei gambit•nse 
7iypanosoma  bntcci rl10desiense 
1i":qHmo.roma  cntzi 
Wuclzaetia  bancrofti 
(  • •) See paragraph 8 of lhe introductory notes. 
Classificatiun 
2 
2 
2 
2 
2 
3 .c.:1 
2 
2 
2 
2 
2 
2 
3 .c.:1 
3 
2 
1'\lltc:s 
------------~------~-------------------------------
FUNGI 
Biological agent  Oassificatiuh 
A.rpe~gillus  fumigatus  2 
Blastomyces demzatitidis (Ajel/omyces dennatiridis)  3 
Candida ctlbicans  2 
Ccmdida lropicalis  2 
Cladoplzialoplzoro  bamiana  (formerly: Xylolzyplta  banticma,  3 
Cladosporium bantianum or triclzoides) 
Coccidioides immitis 
Cryptococcus  neofonnans  var.  neofonnans  (Filobasidiel/a 
neofomzans vat neofonnans) 
Coptococcus  neofomums  vat  gattii  (Filobasidiel/a 
bacil/ispora) 
Emmonsia pan·a var. pan•a 
Emmonsia ptm•a var. crescens 
Epidemzoplryron floccoswn 
fi:msecaea compact" 
Fonsecaea pedrosoi 
3 
2 
2 
2 
2 
2 
2 
2 
Histoplasma  capsulatum  var.  capsulatum  (Ajellomyces  3~ 
capsulatus) 
Histoplasma capsulatwn duboisii 
Madurella grisea 
Madurella mycetomatis 
Microspomm spp. 
Neotestudina rosatii 
Paracoccidioides brasiliensis 
Penicillium mameffei 
Scedosporium apiospennum (Pseudallesclreria boydii) 
Scedosporium prolificans (inflatum) 
Sporot/zri"C sclunckii 
Triclzoplzyton ntbnmt 
Tricltoplzyton spp. 
3 
2 
2 
2 
2 
3 
2 
2 
.2 
2 
2 
2 
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9.  fi.  I'J'JlJ 
93.'8S:EEC - ArL I (2) 
95/30/EC - ArL I 
95/30/EC  - ArL I 
f 95/30/EC - Art.  I 
93/88/EEC- Art. I (2) 
97/59/,EC  - Art.  l 
93/SS/EEC  - Art. 1 (2) 
197/59/EC - Art. 1 
93/88/EEC - Art. 1 (2) .~LV.VEX IV 
PRACTICAL  RECO:\l:\IE~Il·\TIO~S FOR TilE IIE.-\LTII 
SUR\'EILI...-\~CE OF WORKERS 
(Article  I~ (8)) 
I.  The doctor  and/or  the  authority  responsible  fur  the  health 
surveillance of workers expL'Sed  to biological agents must he 
familiar  with  the  exposure  t:onditions  or  cin:umstatll:cs  of 
each WlH"kt:r. 
2.  Health  surveilhtnt:e  vf  workers  must  be  carried  out  in 
accordance with  the principles and pradices of occupational 
medicine: it  must include at least the following  measures: 
keeping  records  of  a  worker's  medical  and  occupa-
titmal history; 
a  personalized  assessment  uf  the  worker's  state  of 
health: 
where  appropriate,  biological  monitoring,  as  well  as 
detection of early and reversible effects. 
Further tests may he decided upon for eat:h worker when he 
is  the suhjet:t of health surveillance, in the light of the most 
recent knowledge available  to occupational medic.:ine. 
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9.n.  J<J<J<J ANNEX V 
1:'1/DICATIO:'I/S CO:"'CER:'III:'IIG CO:'IIT.\1:'11:\IE:'IIT  :\IE.\SURES 
A:'IID  CO:'IIT.\1:'11:\IE:'I/T  LEVELS 
(Articles  15  (J) and lfi  (I)  (a) and (b)) 
Preliminmy note 
The measures contained in  this  Annex shall be  applied  a~wrding 
to the  nature uf the  a~tivities, the  asses.~mcnt uf risk  tu  workers, 
and the  nature of the  biological  agent ~om:erned. 
A. 
Containment measures 
I.  The  workplace  is  to  be  separated  from  Nu 
any other adivities in the same building 
2.  Input air and extract air to  the workplace  No 
are  to  be  filtered  using  (HEPA)  or 
likewise 
2 
3.  Access  is  to  be  restricted  to  nominated  Re~-ummended 
workers only  . 
~- The workplace is  to  be sealable tu permit  No 
disinfection 
5.  Specified disinfection procedures  Yes 
6.  The workplace  is  to be maintained at  an  No 
air pressure negative to atmosphere 
7.  Efficient  vector  wntrol e.g.  rodents  and  Recommended 
insects 
8.  Surfaces impervious to  water and easy  to  Yes,  fur  bench 
clean 
9.  Surfaces  resistant  to  acids,  alkalis,  sol- Recommended 
vents, disinfectants 
10.  Safe storage of a biological agent  Yes 
11.  An observation window, or, alternative, is  Recommended 
to  be  present,  so  that  occupants  can  be 
seen 
12.  A  labDratury  is  to  contain  own  No 
equipment 
B. 
Containmont kvds 
Rewmmended 
Yes,  un extract air 
Yes 
Recommended 
Yes 
Recommended 
Yes 
Yes,  fur  bench and 
flour 
Yes 
Yes 
Rewmmended 
Recommended 
9();f,79.EEC - I\" 
9. n.  19lJ'J 
Yes 
Yes,  on  input  and 
ex1ract  air 
Yes, via  airlock 
Yes 
Yes 
Yes 
Yes 
Yes, 
walls, 
ceiling 
Yes 
for  hench, 
flour  and 
Yes, secure storage 
Yes 
Yes 
90.'n7'l.EEC 
13.  Infected material including any  animal  is  Where appropriate 
to be handled in a safety cabinet or isola-
Yes where infection  Yes 
tor or other suitable containment 
U. Incinerator  for  disposal  of  animal  Recommended 
carcases 
32 
is  by  airborne 
route 
Yes  (available)  Yes,  un site 91l/679;EEC - I\' 
9.  fi.  19<J<) 
AN,\"EX H 
CO:-rf.·\1:'11:\'IE:"'T  FOR 1:'1/DUSTRI:\1.  PROCESSES 
(Article 4 {I) and Article  lti (2)  (a)) 
Group 1 biological agents 
For work with group  l biological agents including life  attenuated 
vaccines,  the  principles of  ~'lK.I<i  occupational safety and hygiene 
should be obse!Ved. 
Group 2,  3 ami 4 biological agems 
ll  may  be  appropriate  Ill  select  and  combine  containment 
requirements from  different  categories  bduw on  the basis  of a 
risk  assessment  related  to  any  particular  process  or  part  of a 
process. 
Containment measures 
I.  Viable org1misms shc.1uld  be handled in  a  Yes 
system  which  physically  separates  the 
process from  the environment 
2 
2.  Exhaust  gases  from  the  closed  system  Minimize release 
should be treated so as to: 
3.  Sample  collection,  addition  of materials  Minimize release 
to a dosed system and transfer of viable 
organisms  to  another  closed  system, 
should be performed so as  to: 
Containment levels 
3 
Yes 
Prevent release 
Prevent release 
·4 
Yes 
Preven 1 release 
Prevent release 
4.  Bulk  c.:ulture  fluids  shoul<f  not  be  Inactivated  by  vali-
remo,·ed  from  the  closed  svstem  unless  dated means 
Inactivated  by  vali- Inactivated  by  vali-
dated  chemical  or  dated  chemical  or 
the viable organisms have  ~>den: 
5.  Seals should be designed so as to:  Minimize release 
6.  Closed systems should be located within  Optiunal 
a controlled area 
(a) Biohazard signs should be posted  Optional 
(b) Access  should be restricted  to  nomi- Optional 
nated personnel only 
physil.:al  means  physical means 
Prevent release 
Optional 
Yes 
Yes 
Prevent release 
Yes,  and  purpose-
built 
Yes 
Yes, via an airlock 
(c) Personnel  should  wear  protet.'tive  Yes, work cl.uthing  Yes  A complete change 
clothing 
(d) Decontamination  and  washing  faci- Yes 
lities  should  be  provided  for 
personnel 
(e) Personnel should shower before Jeav- No 
ing the controlled area 
(f)  Eiiluent  from  sinks  and  showers  No 
should  be  collected  and  inactivated 
before release 
(g) The  controlled  area  should  be 
adequately \'CIItil.ated  to minimize  air 
contamination 
Optional 
Yes  Yes 
Optional  Yes 
Optional  Yes 
Optional  Yes 
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(h) The controlled area should  be  main- No 
tain~d at an air pressure  negative  tu 
atmo$phere 
(i)  Input  air  and  extract  ttir  to  the  cun- No 
trulled area should be  HEPA filtered 
(j)  The  controlled  area  should  be  No 
designed  tll  contain  spillage  of  the 
entire contents of the closed system 
(k) The  controlled  area  should  be  seal- No 
able  to permit fumigation 
2 
(I)  Effluent  treatment 
discharge 
before  final  Inactivated  by  vali-
dated means 
34 
Cont:.inm~nt l~v~ls 
Optional 
Optional 
Optional 
Optional 
Yes 
Yes 
Yes 
Yes 
IJ0/679/EEC- IV 
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90/679/EEC 
Inactivated  hy  vali- Inactivated  by  vali-
dated  chemical  or  dated  chemictd  or 
physical means  physical means ANNEX Vlf 
RECO:\L\IE:'>IDED CODE OF PRACTICE 0:'>1  V..\CCN\TIO:'>I 
(Article  I~ (3)) 
l.  If  the  assessment  referred  to  in  Article  3  (2)  reveals  that 
there  is  a  risk  to  the  health  and  safety of workers  due  to 
their  exposure  to  biological  agents  for which  effective  vac-
cines exist,  their employers should offer them vaccination. 
2.  Vaccination  should  be  carried  out  in  accordance  with 
national law ancVor  practice. 
Workers should be informed of the  benefits and drawbacks 
of both vaccination and non-vaccination. 
3.  Vaccination  must be L>ftered  free  of charge to workers. 
4.  A vaccination certificate may he drawn up which should be 
made available  to  the worker concerned and, on request, to 
the competent authorities. 
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9. n.  I9'J'J 
93/SS.'EEC- Art. I 0) /1.\".W.X l7ll 
l'.\RT A 
Repealed Oirective "ith with its successi,·e amendments 
(referred to by  Art  ide  ~I) 
Council  DirectiYe 90/fl79,cEC (OJ  L 374,  31.  12.1990, p.  1) 
Council  Directive 93.188/EEC  (OJ L 268,  29.  10:  \9'l3, p.  71) 
Commission Directive 95/30/EC (OJ L 155, 6.  7.  1995,  p.  41) 
Commission Directive 97/59;EC (OJ L 282,  15.  10.  1997, p.  33) 
CommissiL'n Directive 97/65/EC (OJ L 335,  6.  12.  1997.  p.  17) 
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9.  h.  1999 90/n79,'EEC 
93/88/EEC 
95/30/EC 
97;59/EC 
97/65/EC 
PART 8 
'  I  •  ,  '-~ . 
Deadlines fur transposition into national h••• 
(referred to in  Artidc 211 
O.:adline  f~>r transpositiun 
28  November  1993 
30 April  199-+ 
30 November 1996 
31  March 1998 
30 June 1998 
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9. tl.  1999 Article 1 
Article 2, point (a) 
Article 2, point (b) 
Article 2, point (c) 
Article 2, point (d) 
Article 3 ( 1) 
Article 3 (2) (a) 
Article 3 (2) (b) 
Article 3 (2) (c) 
Article 3 (2) (d) 
,Directive 901679/EEC 
Article 3 (3), 1st indent 
Article 3 (3), 2nd indent 
Article 3 (3), 3rd indent 
Article 3 (3), 4th indent 
Article 3 (3), 5th indent 
Article 4 
Article 5 
Article 6 
Article 7 (1 ),  1st indent 
Article 7 (1), 2nd indent 
Article 7 (1), 3rd indent 
Article 7 (1), 4th indent 
Article 7 (1), 5th indent 
Article 7 (1), 6th indent 
Article 7 (2) 
Article 7 (3) 
Article 8 (1) (a) to (e) 
Article 8 (2) (a) 
Article 8 (2) (b) 
Article 8 (3) 
Article 9 (1) (a) to (c) 
Article 9 (2), 1st indent -
Article 9 (2), 2nd indent 
Article 9 (2), 3rd indent 
Article 10  (1 ),  1st indent 
Article  10  (1), 2nd indent 
Article  10  (2)  to (6) 
Article  11  (1) 
Article  11  (2), 2nd subparagraph, 1st indent 
Article  11  (2), 2nd subparagraph, 2nd indent 
Article  11  (2),  2nd subparagraph, 3rd indent 
ANNEX IX 
CORRELATIO:"' TABLE 
38 
This Directive 
Article  1 
Article 2,  151  paragraph, point (a) 
Article 2,  1'1 paragraph, point (b) 
Article 2,  ts1 paragraph, point (c) 
Article 2, 2nd paragraph 
Article 3 (  1) 
Article 3 (2),  1st subparagraph 
Article 3 (2), 2nd subparagraph 
Article 3 (2), 3rd subparagraph 
Article 3 (2), 4th subparagraph 
Article 3 (3) (a) 
Article 3 (3) (b) 
Article 3 (3) (c) 
Article 1 (3) (d) 
Article 3 (3) (e) 
Article 4 
Article 5 
Article 6 
Article 7 (1) (a) 
Article 7 (1) (b) 
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